Inside USP - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Inside USP

Control Strategies for Synthetic Therapeutic Peptide APIs— Part I: Analytical Consideration

March 2, 2014

Pharmaceutical Technology

USP evaluates quality attributes for synthetic peptides.

USP Seeks Input on Standards for Plastic Packaging Systems

October 2, 2013

Pharmaceutical Technology

USP seeks input from stakeholders on new and revised standards to mitigate extractables and leachables in plastic packaging systems.

USP Partners Globally for 21st-Century Medicines

July 2, 2013

Pharmaceutical Technology

USP focuses on building worldwide partnerships in standards-setting activities.

Moisture Permeation of Pharmaceutical Packaging

April 2, 2013

Pharmaceutical Technology

USP is proposing a new performance testing standard for moisture permeation of pharmaceutical packaging.

Modernization of USP Standards

February 2, 2013

Pharmaceutical Technology

The US Pharmacopeial Convention contiues to make modernization of standards a top priority in 2013.

USP Further Strengthens Quality Standards for Heparin

September 2, 2012

Pharmaceutical Technology

USP optimizes identification tests and impurities procedures.

Inside USP: US Pharmacopeia Proposes New Standard on Glass Quality

June 2, 2012

Pharmaceutical Technology

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.

Inside USP: A Holistic Approach to Supply-Chain Integrity

March 2, 2012

Pharmaceutical Technology

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.

Inside USP: Global Harmonization Presents Opportunities and Challenges

January 2, 2012

Pharmaceutical Technology

To keep moving forward, the Pharmacopoeial Discussion Group needs industry participation.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here